Q-Line Biotech (NSE:QLINE) OCF Margin %: -0.42% (As of Mar. 2025)


NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
12 GF Score
Price ₹546.50
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech OCF Margin %?

Q-Line Biotech NSE:QLINE -5.15% 12 OCF Margin % is -0.42% as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Q-Line Biotech ranks worse than 62.09% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Q-Line Biotech's Cash Flow from Operations for the six months ended in Mar. 2025 was ₹-13 Mil. Q-Line Biotech's Revenue for the six months ended in Mar. 2025 was ₹3,138 Mil. Therefore, Q-Line Biotech's OCF Margin % for the quarter that ended in Mar. 2025 was -0.42%.

As of today, Q-Line Biotech's current OCF Yield % is -0.10%.

The historical rank and industry rank for Q-Line Biotech's OCF Margin % or its related term are showing as below:

NSE:QLINE' s OCF Margin % Range Over the Past 10 Years
Min: -11.87   Med: -0.42   Max: 13.66
Current: -0.42


During the past 3 years, the highest OCF Margin % of Q-Line Biotech was 13.66%. The lowest was -11.87%. And the median was -0.42%.

NSE:QLINE's OCF Margin % is ranked worse than
62.09% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.82 vs NSE:QLINE: -0.42


Q-Line Biotech OCF Margin % Related Terms


Q-Line Biotech OCF Margin % Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech OCF Margin % Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
OCF Margin %
13.66 -11.87 -0.42

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
OCF Margin % 13.66 -11.87 -0.42

NSE:QLINE vs ABT, SYK, MDT: OCF Margin % Comparison

For the Medical Devices subindustry, Q-Line Biotech's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q-Line Biotech OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Q-Line Biotech's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Q-Line Biotech's OCF Margin % falls into.


NSE:QLINE
12GF Score
Q-Line Biotech Ltd NSE:QLINE
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Q-Line Biotech's OCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-13.22/3137.804
=-0.42 %

Q-Line Biotech's OCF Margin for the quarter that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=-13.22/3137.804
=-0.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -0.42% mean?
Q-Line Biotech (NSE:QLINE) has a OCF Margin % of -0.42% as of Mar. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Q-Line Biotech and its competitors. According to the industry distribution chart, Q-Line Biotech ranks #506 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 62.1%.
Is Q-Line Biotech's OCF Margin % too high?
Q-Line Biotech's current OCF Margin % is -0.42%. Based on the distribution chart, Q-Line Biotech ranks #506 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Q-Line Biotech ranks #506 out of 815 companies for OCF Margin %. This places Q-Line Biotech in the lower half of its industry. The industry median OCF Margin % is 5.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Q-Line Biotech and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Q-Line Biotech's current OCF Margin % is -0.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current OCF Margin % of -0.42%. The current OCF Margin % is -0.42%. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current OCF Margin % is -0.42% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score

Get the complete analysis for NSE:QLINE

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹546.50
Price